Proteolytic inactivation of transforming growth factor beta3 by elastase in venous leg ulcers: implications for clinical trials using topically-applied peptide growth factors.
Schmid
P
P
Itin
P
P
Cox
D
D
D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy* / Q000378:metabolism; D019272:Leukocyte Elastase / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000378:metabolism*; D014945:Wound Healing / Q000502:physiology*
D006133:Growth Substances; D016212:Transforming Growth Factor beta; D019272:Leukocyte Elastase